Optibrium Adopts Cheminformatics Toolkits From OpenEye Scientific

May 12, 2020

High performance libraries provide strong foundation for new developments to StarDrop drug discovery software

CAMBRIDGE, UK and SANTA FE, NEW MEXICO, USA: 12 April, 2020 – Optibrium™ and OpenEye Scientific (OpenEye), leading providers of software and services for drug discovery, today announced that StarDrop™, Optibrium’s software for small molecule design, optimisation and data analysis, is now powered by OpenEye Scientific’s cheminformatics toolkits. These industry-leading cheminformatics libraries offer a robust and performance-orientated foundation that ensures StarDrop will further advance its position as a leading computational software suite and meet the demands posed by future drug discovery projects.

Optibrium’s lead product, StarDrop, is a comprehensive suite of integrated software deployed by many of the world’s leading pharmaceutical and biotech companies to support their drug discovery programs. StarDrop’s seamless integration of the industry-leading libraries and toolkits developed by OpenEye Scientific, including OEChem, OEDepict and OMEGA, enables accelerated development of Optibrium’s in silico drug discovery technologies and artificial intelligence services.

OpenEye Scientific is an industry leader in the field of cheminformatics software for drug discovery, providing highperformance and robust libraries with a developer-friendly Application Programming Interface, supporting the development of highly customisable software solutions and workflows. The company directly supports pharmaceutical and biotechnology companies as well as making its cheminformatics platform available to software companies, such as Optibrium, enabling high-performance cheminformatics software solutions.

Dr. Anthony Nicholls, OpenEye Scientific’s CEO commented: “It’s always exciting when we get the opportunity to empower great people with the same foundational software platform that has allowed us to grow and develop for the last twenty years. Optibrium has always had a fantastic product in StarDrop, and it’s an honour to be a part of what they offer to the pharmaceutical industry.”

Dr Matthew Segall, Optibrium’s CEO, said: “We continue to invest in cutting-edge research to deliver high-quality science and new functionality that is accessible within StarDrop’s intuitive user interface, to the benefit of our global user base. We highly value this collaboration with OpenEye Scientific, a company that shares our commitment to creating best-in-class technologies designed for reliability and performance.”

The companies continue to work closely together to leverage future opportunities to advance their respective platforms.

For further information on StarDrop, please visit, contact [email protected] or call +44 1223 815900.

For more information on OpenEye’s OEChem, OEDepict and OMEGA, go to:, contact [email protected] or call +1-505-473-7385